NEW YORK and SAN DIEGO, Nov. 1,
2021 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq:
HLTH), a healthcare technology company, and Major League Baseball
(MLB) today announced that Cue has been providing all Clubs, as
well as the league office, with its integrated Cue platform, which
features both the portable Cue Health Monitoring System and
easy-to-use Cue COVID-19 tests, throughout the Postseason and World
Series.
The Cue COVID-19 Test for Home and Over The Counter (OTC) Use is
the first FDA-authorized molecular diagnostic test for at-home and
over-the-counter use without physician supervision or a
prescription. Cue's platform is a molecular diagnostic system that
delivers results directly to mobile smart devices – both
Android and iOS – in about 20 minutes.
"The World Series is an iconic time in sports and it's a true
honor to play a role in this year's Fall Classic by helping to keep
players, coaches, staff, umpires, and their families healthy," said
Ayub Khattak, co-founder and CEO of
Cue. "Our fast and accurate testing combined with our platform
that's easy to use, portable, and connected makes health
information more accessible to individuals, which is critical in
today's world."
"Cue has proven to be an effective supplement to our COVID-19
testing program," said Jon Coyles,
MLB's Vice President, Drug, Health & Safety Programs. "Cue's
elegant device and intuitive platform are very simple to use, and
the flexibility provided by the authorization for at-home use has
proven to be a great fit for our industry. We appreciate Cue's
support during the most critical part of our 2021 season and look
forward to expanding the integration of their testing devices in
the future."
MLB's selection of Cue's cutting-edge healthcare technology
demonstrates the league's continued commitment to organizational
health and wellness and protecting its key constituents during the
pandemic while ensuring continuity of games. Together with Cue, MLB
is able to take its health and wellness beyond Club facilities and
ballparks into the homes of players and staff, while maintaining
connectivity through the Cue Integrated Care Platform and Cue
Dashboard.
Cue previously received Emergency Use Authorization from the FDA
in June of 2020 for its Cue COVID-19 Test for use in clinical and
point of care settings. Cue Health's other enterprise customers
include Google, Mayo Clinic, and the NBA.
About Cue Health
Cue Health (Nasdaq: HLTH) is a
healthcare technology company that puts consumers in control of
their health information and places diagnostic information at the
center of care. Cue Health enables people to manage their health
through real-time, actionable, and connected health information,
offering individuals and their healthcare providers easy access to
lab-quality diagnostics anywhere, anytime, in a device that fits in
the palm of the hand. Cue Health's first-of-its-kind COVID-19 test
was the first FDA-authorized molecular diagnostic test for at-home
and over-the-counter use without physician supervision. Outside
the United States, Cue Health has
received the CE mark in the European Union, Interim Order
authorization from Health Canada, and regulatory approval from
India's Central Drugs Standard
Control Organisation. Cue was founded in 2010 and is headquartered
in San Diego. For more
information, please visit www.cuehealth.com.
About MLB
Major League Baseball (MLB) is the most
historic professional sports league in the United States and consists of 30 member
clubs in the U.S. and Canada,
representing the highest level of professional baseball. Led by
Commissioner Robert D. Manfred, Jr.,
MLB remains committed to making an impact in the communities of the
U.S., Canada and throughout the
world, perpetuating the sport's larger role in society and
permeating every facet of baseball's business, marketing and
community relations endeavors. MLB has consistently been the
most-attended sport in North
America and registered records in games and minutes watched
this season on MLB.TV. With the continued success of MLB Network
and MLB digital platforms, MLB continues to find innovative ways
for its fans to enjoy America's National Pastime and a truly global
game. For more information on Major League Baseball, visit
www.MLB.com.
Forward-Looking Statements
Statements in this press
release about future expectations, plans and prospects, as well as
any other statements regarding matters that are not historical
facts, may constitute "forward-looking statements". The words,
without limitation, "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "plan," "potential,"
"predict," "project," "should," "target," "will," "would" and
similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain
these or similar identifying words. Actual results may differ
materially from those indicated by such forward-looking statements
as a result of various important factors, including the factors
discussed in the "Risk Factors" section of the prospectus dated
September 23, 2021 filed by Cue with
the SEC. Any forward-looking statements contained in this press
release are based on the current expectations of Cue's management
team and speak only as of the date hereof, and Cue specifically
disclaims any obligation to update any forward-looking statement,
whether as a result of new information, future events or
otherwise.
These products have not been FDA cleared or approved; but
have been authorized by FDA under an EUA. These products have been
authorized only for the detection of nucleic acid from SARS-CoV-2,
not for any other viruses or pathogens. The emergency use of these
products is only authorized for the duration of the declaration
that circumstances exist justifying the authorization of emergency
use of in vitro diagnostics for detection and/or diagnosis of
COVID-19 under Section 564(b)(1) of the Federal Food, Drug and
Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the
declaration is terminated or authorization is revoked
sooner.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cue-health-provides-molecular-covid-19-testing-to-mlb-clubs-during-the-postseason-and-world-series-301412854.html
SOURCE Cue Health Inc.